Analyst Group

Analyst Group comments on that a long-term study shows improved quality of life with Nosa Plugs’ smell training kit, Smell Training

Källa: MFN
Positiv

Sammanfattning

En ny klinisk studie publicerad av Karolinska Institutet, Lunds universitet och Skånes universitetssjukhus visar att Nosa Plugs produkt "Smell Training" signifikant förbättrar luktsinne och livskvalitet hos individer med nedsatt luktsinne. Studien indikerar en stark potential för produkten att kvalificera sig för subventioner på flera marknader, vilket Nosa Plugs planerar att ansöka om.

Analys

Studien från Karolinska Institutet, Lunds universitet och Skånes universitetssjukhus stärker den vetenskapliga grunden för Nosa Plugs produkt "Smell Training". De positiva resultaten, som visar signifikant förbättrad luktförmåga och livskvalitet jämfört med standardbehandlingar, ökar sannolikheten för att produkten kommer att godkännas för subventioner på flera europeiska marknader. Detta skulle kunna leda till ökad tillgänglighet, högre försäljningsvolymer och fungera som en viktig referens vid expansion till nya marknader. Nosa Plugs avser att initiera ansökningsprocesser inom kort. Det är dock viktigt att notera att detta är en kommentar från Analyst Group, som erhållit ersättning för att publicera den.

Nosa Plugs AB (“Nosa Plugs” or “the Company”) announced on 11 December 2025 that a new clinical study conducted by Karolinska Institutet in collaboration with Lund University and Skåne University Hospital has been published regarding the Company’s product Smell Training. The study shows that Smell Training significantly improves both perceived sense of smell and quality of life in individuals with olfactory loss (hyposmia). The positive study results indicate a strong likelihood that the product will qualify for reimbursement systems in several markets, and Nosa Plugs is expected to initiate application processes shortly in a select number of European countries.

Nosa Plugs AB (“Nosa Plugs” or “the Company”) announced on 11 December 2025 that a new clinical study conducted by Karolinska Institutet in collaboration with Lund University and Skåne University Hospital has been published regarding the Company’s product Smell Training. The study shows that Smell Training significantly improves both perceived sense of smell and quality of life in individuals with olfactory loss (hyposmia). The positive study results indicate a strong likelihood that the product will qualify for reimbursement systems in several markets, and Nosa Plugs is expected to initiate application processes shortly in a select number of European countries.

In summary, the newly published one-year clinical study from Karolinska Institutet, Lund University and Skåne University Hospital reinforce the scientific support for Nosa Plugs’ Smell Training by demonstrating significantly improved olfactory function and quality of life compared with today’s standard treatments. Together with the positive findings from the 2024 study, this indicates that the product now has strong prospects of qualifying for reimbursement in several European markets, a process the Company intends to initiate shortly. Such approval would increase accessibility, drive higher usage and sales volumes, and serve as important proof of concept and reference in connection with expansion into new markets.

Read Analyst Group’s comment here

About Analyst Group: One of Sweden's leading equity research boutiques with focus on small and medium-sized listed companies.Read more about Analyst Group This is a press release from Analyst Group regarding the publication of a comment on Nosa Plugs. Readers may assume that Analyst Group has received compensation for making the comment. The Company has not been given an opportunity to influence the parts where Analyst Group has had opinions about the Company, future valuation or anything else that could be considered a subjective assessment.